Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study

View ORCID ProfileJocelyn Dupuis, Pierre Laurin, Jean-Claude Tardif, Leslie Hausermann, Camille Rosa, Marie-Claude Guertin, Karen Thibaudeau, Lyne Gagnon, Frank Cesari, Martin Robitaille, John E. Moran
doi: https://doi.org/10.1101/2021.10.04.21264483
Jocelyn Dupuis
aMontreal Heart Institute Research Center, Montreal, Quebec, Canada
bDepartment of Medicine of Université de Montréal, Montreal, Quebec, Canada
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jocelyn Dupuis
  • For correspondence: dupuisj{at}icloud.com
Pierre Laurin
cIngenew Pharmaceuticals, Montreal, Quebec, Canada
MSc Pharm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Claude Tardif
aMontreal Heart Institute Research Center, Montreal, Quebec, Canada
bDepartment of Medicine of Université de Montréal, Montreal, Quebec, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie Hausermann
aMontreal Heart Institute Research Center, Montreal, Quebec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camille Rosa
dMontreal Health Innovations Coordination Center, Montreal, Quebec, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Claude Guertin
dMontreal Health Innovations Coordination Center, Montreal, Quebec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Thibaudeau
cIngenew Pharmaceuticals, Montreal, Quebec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lyne Gagnon
cIngenew Pharmaceuticals, Montreal, Quebec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Cesari
cIngenew Pharmaceuticals, Montreal, Quebec, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Robitaille
cIngenew Pharmaceuticals, Montreal, Quebec, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John E. Moran
cIngenew Pharmaceuticals, Montreal, Quebec, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: October 2021 to August 2025

AbstractFullPdf
Oct 2021118838231
Nov 202141611663
Dec 20216624966
Jan 202242517951
Feb 202218011725
Mar 202221412512
Apr 20221308430
May 202212510820
Jun 2022799022
Jul 2022867311
Aug 2022853722
Sep 2022841717
Oct 202286222
Nov 202278316
Dec 2022521111
Jan 2023461015
Feb 202341412
Mar 202336318
Apr 202336117
May 202316315
Jun 20231595
Jul 20232039
Aug 2023271114
Sep 202320617
Oct 20231849
Nov 2023371313
Dec 20232304
Jan 202418313
Feb 202411712
Mar 202420513
Apr 202425919
May 20241129
Jun 202438810
Jul 202423313
Aug 2024311014
Sep 202438816
Oct 20241637
Nov 202422014
Dec 202421217
Jan 202530619
Feb 2025343022
Mar 2025634326
Apr 202532334
May 202540822
Jun 2025511527
Jul 2025341620
Aug 2025303
Back to top
PreviousNext
Posted October 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study
Jocelyn Dupuis, Pierre Laurin, Jean-Claude Tardif, Leslie Hausermann, Camille Rosa, Marie-Claude Guertin, Karen Thibaudeau, Lyne Gagnon, Frank Cesari, Martin Robitaille, John E. Moran
medRxiv 2021.10.04.21264483; doi: https://doi.org/10.1101/2021.10.04.21264483
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study
Jocelyn Dupuis, Pierre Laurin, Jean-Claude Tardif, Leslie Hausermann, Camille Rosa, Marie-Claude Guertin, Karen Thibaudeau, Lyne Gagnon, Frank Cesari, Martin Robitaille, John E. Moran
medRxiv 2021.10.04.21264483; doi: https://doi.org/10.1101/2021.10.04.21264483

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)